All Stories

  1. Abstract 3151: Genetic profiling of circulating tumor cells (CTC) in metastatic breast cancer (MBC) patients:
  2. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations
  3. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies
  4. PD08-07 MOLECULAR PROGRESSION OF GLEASON 6 PROSTATE CANCER: TRACKING OF SPECIFIC CLONES BY IMAGE-GUIDED BIOPSY
  5. 832 Molecular profiling of prostate cancer derived from serial MRI targeted prostate biopsy in men on active surveillance
  6. Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing
  7. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation
  8. Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
  9. Intra-tumor genetic heterogeneity in rectal cancer
  10. Abstract A1-43: Targeted amplicon-based next-generation sequencing of routine solid tumor specimens to detect clinically relevant somatic alterations
  11. Next-Generation Sequencing of Tubal Intraepithelial Carcinomas
  12. Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment
  13. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands
  14. Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors
  15. Integrative molecular profiling of routine clinical prostate cancer specimens
  16. P3.01 * Development and validation of a scalable next-generation sequencing system for assessing recurrent somatic alterations in solid tumors
  17. Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors
  18. Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma
  19. 187 Targeted genomic profiling of penile squamous cell carcinoma using the Oncomine cancer research panel